 |
 |

CD8+ Epidermotropic Cytotoxic T-Cell Lymphoma With Peripheral Blood and Central Nervous System Involvement
Camille E. Introcaso, MD;
Ellen J. Kim, MD;
Jennifer Gardner, MD;
Jacqueline M. Junkins-Hopkins, MD;
Carmela C. Vittorio, MD;
Alain H. Rook, MD
Arch Dermatol. 2008;144(8):1027-1029.
Background Most cutaneous T-cell lymphomas demonstrate a malignant population with a CD4+ phenotype. In rare cases, CD8+ phenotypes have been described based on immunostaining of skin specimens. Although some CD8+ lymphomas have an indolent course, others, such as CD8+ epidermotropic cytotoxic T-cell lymphomas, are typically more aggressive. To our knowledge, involvement of peripheral blood or cerebrospinal fluid with a malignant population of CD8+ cells demonstrated by flow cytometry and T-cell receptor gene rearrangement has not been previously described.
Observations We describe a patient with a CD8+ cutaneous T-cell lymphoma with an initially indolent course and early stage diagnosed on the basis of a skin biopsy specimen. However, when flow cytometry was performed looking specifically at CD8+/CD4– cells in the peripheral blood and cerebrospinal fluid, a malignant population of CD8+/CD4–/CD26–/CD7– cells was discovered.
Conclusions It is important for prognosis and treatment to be able to identify CD8+ epidermotropic cytotoxic T-cell lymphoma and separate it from other relatively indolent CD8+ lymphomas. Furthermore, detection of an abnormal CD8+/CD26–/CD7– T-cell population within the peripheral blood has important prognostic and therapeutic implications. The use of flow cytometry looking for abnormal CD8+ populations in the peripheral blood or cerebrospinal fluid can assist with this critical information.
Author Affiliations: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLE
This Month in Archives of Dermatology
Arch Dermatol. 2008;144(8):978.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models
Cornejo et al.
Blood 2009;113:2746-2754.
ABSTRACT
| FULL TEXT
|